Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,053-2,064 of 4,306
Behavioral study icon
CompletedNCT00280813

Alcohol Use Disorders in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Baltimore
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 22 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
WithdrawnNCT01567124

Alleviating the Metabolic Side Effects of Antipsychotic Medications

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Ballarat
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Australia
Sponsor
Baker Heart and Diabetes Institute
Condition
Schizophrenia
Drug study icon
CompletedISRCTN68824876

Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including London
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Imperial College London
Condition
Schizophrenia
Drug study icon
CompletedNCT00728195

3 Fixed Doses of JNJ-37822681 for schizophrenia

This study is completed in Bulgaria, in Estonia, in Lithuania, .... It is testing 3 Fixed Doses of JNJ-37822681 for schizophrenia.

Multiple locations, including Burgas
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Bulgaria, Estonia, Lithuania, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
CompletedNCT01009047

Extended-Release (ER) Paliperidone for schizophrenia

This study is completed in the United States, in India, in Romania, .... It is testing Extended-Release (ER) Paliperidone for schizophrenia.

Multiple locations, including Dothan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 12 Years to 17 Years
Countries
United States, India, Romania, ...
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT00524043

One Dosage of Paliperidone Extended Release (ER) for schizophrenia

This study is completed in the United States, in India, and in Taiwan. It is testing One Dosage of Paliperidone Extended Release (ER) for schizophrenia.

Multiple locations, including Cerritos
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
United States, India, Taiwan
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
CompletedNCT00566631

Paliperidone Extended-Release (ER) Tablets for schizophrenia

This study is completed in France, in Croatia, in Germany, .... It is testing Paliperidone Extended-Release (ER) Tablets for schizophrenia.

Multiple locations, including Zagreb
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
France, Croatia, Germany, ...
Sponsor
Janssen-Cilag International NV
Condition
Schizophrenia
Drug study icon
CompletedNCT01299389

Paliperidone Palmitate for schizophrenia

This study is completed in Japan, in South Korea, and in Taiwan. It is testing paliperidone Palmitate for schizophrenia.

Multiple locations, including Fujioka
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 20 Years
Countries
Japan, South Korea, Taiwan
Sponsor
Janssen Pharmaceutical K.K.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.